Citation Information :
Venugopalan V, Elkal M, Behere RV, Praharaj SK, Kanaradi H. A Study on Alexithymia, Quality of Life, and Facial Emotion Recognition Abilities in Somatoform Disorders. J Postgrad Med Edu Res 2018; 52 (3):110-116.
Aim: To assess alexithymia and quality of life among patients of somatoform disorders (SFD) compared with healthy control subjects and to assess the association between alexithymia and facial emotion recognition ability and its influence on quality of life within diagnostic subgroups of SFD.
Materials and methods: Forty-three patients diagnosed to have SFD (International Classification of Diseases (ICD)-10) were assessed on the World Health Organization (WHO) SFD symptom checklist, Toronto Alexithymia Scale-26 (TAS-26), Tool for Recognition of Emotions in Neurological Disorders (TRENDS) and WHO Quality of Life (QOL) BREF to measure quality of life. They were compared with a control group of 47 healthy subjects.
Results: Patients with SFD had greater alexithymia scores and poorer quality of life compared with controls. A novel observation was the inverse correlation between alexithymia and facial emotion recognition deficit, specifically in the diagnostic subgroup of persistent somatoform pain disorder compared with other diagnostic subtypes.
Conclusion: Alexithymia is an important trait influencing quality of life, especially in patients with a diagnosis of persistent somatoform pain disorder and is associated with deficits in facial emotion recognition.
Clinical significance: Association between alexithymia and facial emotion recognition is predominant in patients with somatoform pain disorder. Psychological interventions focusing on improving social cognition could potentially play a role in improving the quality of life in patients with persistent somatoform pain disorder.
Ustun, TB.; Sartorius, N. Mental illness in general health care. Chichester: Wiley; 1995.
Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000 Jul- Aug;69(4):205-215.
Sharpe M, Carson A. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 2001 May;134(9 Pt 2):926-930.
Ormel J, Von Korff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994 Dec;272(22):1741-1748.
Steckel, W.; Paul, C.; Gutheil, EA. The interpretation of dreams: new developments and technique. New York: Liveright; 1943.
Kellner R. Somatization: theories and research. J Nerv Ment Dis 1990 Mar;178(3):150-160.
Duddu V, Isaac MK, Chaturvedi SK. Alexithymia in somatoform and depressive disorders. J Psychosom Res 2003 May; 54(5):435-438.
Sifneos PE. The prevalence of “Alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 1973;22(2):255-262.
Feldmanhall O, Dalgleish T, Mobbs D. Alexithymia decreases altruism in real social decisions. Cortex 2013 Mar;49(3):899-904.
Sriram TG, Chaturvedi SK, Gopinath PS, Subbakrishna DK. Assessment of alexithymia: psychometric properties of toronto alexithymia scale (TAS)—a preliminary report. Indian J Psychiatry 1987 Apr;29(2):133-138.
Sriram, TG. Alexithymia: a controlled study in patients with psychogenic pain disorder. Thesis submitted to Bangalore University, Bengaluru. 1986
Bach M, Bach D Alexithymia in somatoform disorder and somatic disease: a comparative study. Psychother Psychosom 1996;65(3):150-152.
Cox BJ, Kuch K, Parker JD, Shulman ID, Evans RJ. Alexithymia in somatoform disorder patients with chronic pain. J Psychosom Res 1994 Aug; 38(6):523-527.
Steinweg DL, Dallas AP, Rea WS. Fibromyalgia: unspeakable suffering, a prevalence study of alexithymia. Psychosomatics 2011 May-Jun;52(3):255-262.
Burba B, Oswald R, Grigaliunien V, Neverauskiene S, Jankuviene O, Chue P. A controlled study of alexithymia in adolescent patients with persistent somatoform pain disorder. Can J Psychiatry 2006 Jun;51(7):468-471.
Garcia Nuñez D, Rufer M, Leenen K, Majohr KL, Grabe H, Jenewein J. Quality of life and alexithymia in somatoform pain disorder. Schmerz 2010 Feb;24(1):62-68.
Subric-Wrana C, Beutel ME, Knebel A, Lane RD. Theory of mind and emotional awareness deficits in patients with somatoform disorders. Psychosom Med 2010 May;72(4):404-411.
Larsen JK, Brand N, Bermond B, Hijman R. Cognitive and emotional characteristics of alexithymia: a review of neurobiological studies. J Psychosom Res 2003 Jun;54(6):533-541.
Kano M, Fukudo S. The alexithymic brain: The neural pathways linking alexithymia to physical disorders. Biopsychosoc Med 2013 Jan;7(1):1.
Pedrosa Gil F, Ridout N, Kessler H, Neuffer M, Schoechlin C, Traue HC, Nickel M. Facial emotion recognition and alexithymia in adults with somatoform disorders. Depress Anxiety 2009;26(1):E26-E33.
Schönenberg M, Mares L, Smolka R, Jusyte A, Zipfel S, Hautzinger M. Facial affect perception and mentalizing abilities in female patients with persistent somatoform pain disorder. Eur J Pain 2014 Aug;18(7):949-956.
Shamasunder C, Sriram TG, Murali Raj SG, Shanmugham V. Validity of a short 5-item version of the general health questionnaire (g.h.q). Indian J Psychiatry 1986 Jul-Sep;28(3):217-219.
Taylor GJ, Ryan DP, Bagby RM. Towards the development of a new self-report alexithymia scale. Psychother Psychosom 1985;44(4):191-199.
Wise TN, Simpson N, Sheridan MJ. Comparison of 26-item and 20-item versions of the Toronto Alexithymia Scale for psychiatric outpatients. Psychol Rep 2000 Aug;87(1):127-132.
Tacchini, G.; Janca, A.; Isaac, M. Somatoform disorder schedule who international study of somatoform disorders study protocols and instruments. Geneva: WHO; 1993.
Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group. Qual Life Res 2004 Mar;13(2):299-310.
Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes 2003 Aug;1:29.
Behere RV, Raghunandan V, Venkatasubramanian G, Subbakrishna DK, Jayakumar PN, Gangadhar B. TRENDS- A tool for recognition of emotions in neuropsychiatric disorders. Indian J Psychol Med 2008;30(1):32-38.
Bankier B, Aigner M, Bach M. Alexithymia in DSM-IV disorder: comparative evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder, and depression. Psychosomatics 2001 May-Jun;42(3):235-240.
Duddu V, Isaac MK, Chaturvedi SK. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int Rev Psychiatry 2006 Feb;18(1):25-33.
Geenen R, van Ooijen-van der Linden L, Lumley MA, Bijlsma JW, van Middendorp H. The match mismatch model of emotional regulation strategies in fibromyalgia. J Psychosom Res 2012 Jan;72(1):45-50.
da Silva AN, Vasco AB, n JC. Alexithymia and emotional processing: a mediation model. J Clin Psychol 2016 Dec;73(9): 1196-1205.